selegiline has been researched along with Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustine, EF; Auinger, P; Constantinescu, R; Elm, J; Khadim, L; Kieburtz, K; Sharma, S | 1 |
Barna, G; Magyar, K; Szende, B | 1 |
Lengyel, J; Magyar, K; Szatmáry, I; Szende, B; Tarczali, J | 1 |
Bocsi, J; Bökönyi, G; Kéri, G; Magyar, K; Szende, B; Timár, F | 1 |
1 review(s) available for selegiline and Melanoma
Article | Year |
---|---|
The neuroprotective and neuronal rescue effects of (-)-deprenyl.
Topics: Animals; Antiparkinson Agents; Benzylamines; Biotransformation; Brain; Humans; Melanoma; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Rats; Selegiline; Tissue Distribution; Tumor Cells, Cultured | 1998 |
1 trial(s) available for selegiline and Melanoma
Article | Year |
---|---|
Malignant melanoma in early-treated Parkinson's disease: the NET-PD trial.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Double-Blind Method; Female; Humans; Incidence; Male; Melanoma; Middle Aged; National Institutes of Health (U.S.); Neuroprotective Agents; Parkinson Disease; Selegiline; Skin Neoplasms; United States; Young Adult | 2014 |
2 other study(ies) available for selegiline and Melanoma
Article | Year |
---|---|
Cytoprotective effect of (-)-deprenyl, (-)desmethyl-deprenyl and (-)deprenyl-N-oxide on glutathione depleted A-2058 melanoma cells.
Topics: Amphetamines; Buthionine Sulfoximine; Cell Death; Cell Line, Tumor; Cytoprotection; Drug Interactions; Flow Cytometry; Glutathione; Humans; Melanoma; Monoamine Oxidase Inhibitors; Radiation-Sensitizing Agents; Selegiline; Serum | 2010 |
Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites.
Topics: Adrenergic Agents; Apoptosis; Caspase 3; Caspases; Cell Survival; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Melanoma; Methamphetamine; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Proadifen; Selegiline; Tumor Cells, Cultured | 2001 |